000 01124 a2200289 4500
005 20250515075448.0
264 0 _c20071106
008 200711s 0 0 eng d
022 _a0090-3493
024 7 _a10.1097/01.CCM.0000277255.94441.78
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHunt, Matthew A
245 0 0 _aCaveats for triple-H therapy in the management of vasospasm after aneurysmal subarachnoid hemorrhage.
_h[electronic resource]
260 _bCritical care medicine
_cAug 2007
300 _a1985-6 p.
_bdigital
500 _aPublication Type: Comment; Editorial
650 0 4 _aCerebrovascular Circulation
_xdrug effects
650 0 4 _aHemodilution
_xadverse effects
650 0 4 _aHumans
650 0 4 _aPlasma Substitutes
_xadverse effects
650 0 4 _aSubarachnoid Hemorrhage
_xtherapy
650 0 4 _aVasoconstrictor Agents
_xadverse effects
650 0 4 _aVasospasm, Intracranial
_xtherapy
700 1 _aBhardwaj, Anish
773 0 _tCritical care medicine
_gvol. 35
_gno. 8
_gp. 1985-6
856 4 0 _uhttps://doi.org/10.1097/01.CCM.0000277255.94441.78
_zAvailable from publisher's website
999 _c17200229
_d17200229